JPH0513133B2 - - Google Patents

Info

Publication number
JPH0513133B2
JPH0513133B2 JP23201284A JP23201284A JPH0513133B2 JP H0513133 B2 JPH0513133 B2 JP H0513133B2 JP 23201284 A JP23201284 A JP 23201284A JP 23201284 A JP23201284 A JP 23201284A JP H0513133 B2 JPH0513133 B2 JP H0513133B2
Authority
JP
Japan
Prior art keywords
leptomycin
administration
days
cells
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP23201284A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61109717A (ja
Inventor
Teruhiko Betsupu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP23201284A priority Critical patent/JPS61109717A/ja
Publication of JPS61109717A publication Critical patent/JPS61109717A/ja
Publication of JPH0513133B2 publication Critical patent/JPH0513133B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP23201284A 1984-11-02 1984-11-02 抗腫瘍剤 Granted JPS61109717A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23201284A JPS61109717A (ja) 1984-11-02 1984-11-02 抗腫瘍剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23201284A JPS61109717A (ja) 1984-11-02 1984-11-02 抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS61109717A JPS61109717A (ja) 1986-05-28
JPH0513133B2 true JPH0513133B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-02-19

Family

ID=16932566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23201284A Granted JPS61109717A (ja) 1984-11-02 1984-11-02 抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS61109717A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002338551A1 (en) * 2001-04-27 2002-11-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
JP4480128B2 (ja) * 2002-11-20 2010-06-16 独立行政法人科学技術振興機構 マトリックスメタロプロテアーゼ−９の産生を阻害するための薬剤
HRP20120464T1 (hr) 2007-12-20 2012-07-31 Pharma@Mar Antitumorski spojevi
JP5841072B2 (ja) 2010-02-10 2016-01-06 イミュノジェン・インコーポレーテッド Ｃｄ２０抗体およびその使用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Also Published As

Publication number Publication date
JPS61109717A (ja) 1986-05-28

Similar Documents

Publication Publication Date Title
Seifert et al. Comparison of continuously infused 5‐fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma
Wittes et al. Combination chemotherapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck
JP2002537333A (ja) 相乗作用性抗腫瘍組成物
EA008090B1 (ru) Фармацевтические композиции соединения платины
US5049396A (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer sensitive to treatment
CZ301482B6 (cs) Prostredky a použití ET743 k lécbe rakoviny
WO1994005299A1 (en) Medicinal composition
EP0774255A1 (en) Use of ursolic acid for the manufacture of a medicament for suppressing metastasis
NL8301913A (nl) Middel voor het versterken van de antitumor activiteit van een middel tegen tumoren.
JPH0513133B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Iigo et al. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in Lewis lung carcinoma and B16 melanoma
RU2240793C1 (ru) Противоопухолевое средство
EP0283065A1 (en) Combinations of FU and BVU as anti-adenocarcinoma agents
JPH07277964A (ja) 抗腫瘍剤
US6593303B1 (en) Anti-tumor synergetic composition
JPH02235813A (ja) 抗腫瘍剤
US4600573A (en) Compositions and method for alleviating the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea
EP1200099B1 (en) Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds
JPH0120128B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0616561A (ja) 抗レトロウイルス剤
WO2000074683A1 (fr) Potentialisateurs d'effet antitumoral
JPH04182427A (ja) キサントシリンｘジメチルエーテルを含有する抗腫瘍剤
JPS63146839A (ja) プテロシン系化合物を含んで成る制癌剤
KR20020070115A (ko) 항종양제
JPH0145450B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term